Agnieszka Skrobała

Dr. Agnieszka Skrobała


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Radiology and Oncology
Verified
Journal Article
Open access
PDF file
IPIgor Piotrowski
Igor Piotrowski
KKKatarzyna Kulcenty
Katarzyna Kulcenty
WSWiktoria Suchorska
Wiktoria Suchorska
ASAgnieszka Skrobała
Agnieszka Skrobała
MSMałgorzata Skórska
Małgorzata Skórska
Julian MalickiJulian Malicki
Julian Malicki
Background: Although the effects of high dose radiation on human cells and tissues are relatively well defined, there is no consensus regarding the effects of low and very low radiation doses on the organism. Ionizing radiation has been shown to induce gene mutations and chromosome aberrations which are known to be involved in the process of carcinogenesis. The induction of secondary cancers is a challenging long-term side effect in oncologic patients treated with radiation. Medical sources of radiation like intensity modulated radiotherapy used in cancer treatment and computed tomography used in diagnostics, deliver very low doses of radiation to large volumes of healthy tissue, which might contribute to increased cancer rates in long surviving patients and in the general population. Research shows that because of the phenomena characteristic for low dose radiation the risk of cancer induction from exposure of healthy tissues to low dose radiation can be greater than the risk calculated from linear no-threshold model. Epidemiological data collected from radiation workers and atomic bomb survivors confirms that exposure to low dose radiation can contribute to increased cancer risk and also that the risk might correlate with the age at exposure. Conclusions: Understanding the molecular mechanisms of response to low dose radiation is crucial for the proper evaluation of risks and benefits that stem from these exposures and should be considered in the radiotherapy treatment planning and in determining the allowed occupational exposures.

1 April 2017 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
Julian MalickiJulian Malicki
Julian Malicki
RBRitva Bly
Ritva Bly
MBMireille Bulot
Mireille Bulot
JGJean-Luc Godet
Jean-Luc Godet
AJAndreas Jahnen
Andreas Jahnen
HJHannu Jarvinen
Hannu Jarvinen


1 March 2015 in Reports of Practical Oncology and Radiotherapy
Verified
Journal Article
Closed access
ABAnna Bandurska-Luque
Anna Bandurska-Luque
TPTomasz Piotrowski
Tomasz Piotrowski
ASAgnieszka Skrobała
Agnieszka Skrobała
ARAdam Ryczkowski
Adam Ryczkowski
KAKrystyna Adamska
Krystyna Adamska
JKJoanna Kaźmierska
Joanna Kaźmierska
This prospective study aims to assess feasibility of helical tomotherapy (HT) for craniospinal irradiation (CSI) and perform dosimetric comparison of treatment plans for both HT and 3D conformal radiotherapy (3DCRT). CSI is a challenging procedure. Large PTV size requires field matching due to technical limitations of standard linear accelerators, which cannot irradiate such volumes as a single field. HT could help to avoid these limitations as irradiation of long fields is possible without field matching. Three adults were enrolled from 2009 to 2010. All patients received radiochemotherapy. Treatment plans in prone position for 3DCRT and in supine position for HT were generated. The superior plan was used for patients' irradiation. Plans were compared with the application of DVH, Dx parameters - where x represents a percentage of the structure volume receiving a normalized dose and homogeneity index (HI). All patients received HT irradiation. The treatment was well tolerated. The HT plans resulted in a better dose coverage and uniformity in the PTV: HI were 5.4, 7.8, 6.8 for HT vs. 10.3, 6.6, 10.4 for 3DCRT. For most organs at risk (OARs), the D(V80) was higher for HT than for 3DCRT, whereas D(V5) was lower for HT. HT is feasible for CSI, and in comparison with 3DCRT it improves PTV coverage. HT reduces high dose volumes of OARs, but larger volumes of normal tissue receive low radiation dose. HT requires further study to establish correlations between dosimetrical findings and clinical outcomes, especially with regard to late sequelae of treatment.

1 August 2014 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
Julian MalickiJulian Malicki
Julian Malicki
RBRitva Bly
Ritva Bly
MBMireille Bulot
Mireille Bulot
JGJean-Luc Godet
Jean-Luc Godet
AJAndreas Jahnen
Andreas Jahnen
HJHannu Jarvinen
Hannu Jarvinen

1 August 2017 in Cancer/Radiothérapie
Verified
Journal Article
Closed access
ASAgnieszka Skrobała
Agnieszka Skrobała
SAS. Adamczyk
S. Adamczyk
MKMarta Kruszyna-Mochalska
Marta Kruszyna-Mochalska
MSM. Skórska
M. Skórska
AKA. Konefał
A. Konefał
Julian MalickiJulian Malicki
Julian Malicki